Stock Trading Canary

Built: 2026-10-19T16:02:49+00:00 · 中文

← South Korea

SOUTH KOREA · OPENDART

Cellromax Science Co., Ltd.

셀로맥스사이언스 · 471820 · KOSDAQ · Healthcare · Pharmaceutical Retailers

Score

Not ranked: no net buying on the exchange by an individual insider in the last 180 days.

Insiders' buying price vs the latest close

Insiders paid 5,280.00 KRW a share on average (1 purchase line, 1 buyer, 2026-01-19 – 2026-01-19). The close on 2026-10-16 was 24.9% below that price.

Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.

Insider trades on the exchange

Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.

Trade dateInsiderRoleTradeSharesPriceValueFiling
2026-01-19KIM SEONG RAKPresidentBought on the exchange10,000₩5,280₩52.8MDART ↗
Other changes in holdings · 9

Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.

DateInsiderRoleReasonSharesFiling
2026-04-01YANG INKYOUSenior managing directorTreasury stock bonus(+)10,172DART ↗
2026-04-01SEO JI HYEDirectorTreasury stock bonus(+)5,000DART ↗
2026-04-01SEO JI WHANManaging directorTreasury stock bonus(+)2,034DART ↗
2026-01-01SEO JI HYEDirectorNew appointment(+)611,451DART ↗
2025-04-01SEO JI WHANManaging directorTreasury stock bonus(+)2,034DART ↗
2025-04-01YANG INKYOUSenior managing directorTreasury stock bonus(+)10,172DART ↗
2024-12-13SEO JOUNG MINCEO신규상장(+)4,110,200DART ↗
2024-12-13KIM SEONG RAKPresident신규상장(+)100,000DART ↗
2024-12-13MOON MIN SUN10% shareholder신규상장(+)2,764,800DART ↗